Buehlmann


Eiken Chemical Co., Ltd.


Eiken

EIKEN CHEMICAL CO., LTD., from its foundation in 1939, has been committed to contributing to public health and the prevention ofepidemics. In 1949, EIKEN CHEMICAL became the first Japanese company to successfully commercialize the manufacture of powdered culture media for microbiological investigations.

In addition to microbiological diagnosis, EIKEN CHEMICAL has played an active role in medical progress and public health through the development of clinical diagnostic aids vital to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, in vivo diagnostics (contrast media), and automatic analyzers.

EIKEN CHEMICAL has established itself as a leader in the clinical diagnostics market, and maintains its commitment to public health through the development of products and technologies that fill needs at the cutting edge of contemporary medicine.

EIKEN products are very popular in R&D Projects and Clinical Studies. The main product is 2-5A SYNTHETASE RIA (see product list). The 2-5A Synthetase kit is very useful for the evaluation and monitoring of various types of infections (HIV), monitoring of efficacy when treated with IFN, or desease evolution such as SLE.

BÜHLMANN officially represents EIKEN CHEMICAL in Switzerland and in other key markets around the world.

List of actually requested Eiken products in Switzerland and other key markets worldwide. more

Visit Eiken Homepage.

Contact

BÜHLMANN Laboratories AG
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch

Your local distributor
Order
About us
Job opportunities

News

BUHLMANN as gold sponsor of the 5th Santorini Pharmacogenetics Conference

Functional Genomics Towards Personalized Health Care The 5th Santorini Conference will take place in Thira, Greece, on September 30th , October 1st and 2  more

Measuring of Mineralwaters and Softdrinks on Arena and Aquakem

The high expectations in speed, accuracy and precision have been achieved in an evaluation study on Arena 30 at Feldschlösschen (Carlsberg Group), Rheinfe  more

BÜHLMANN Calprotectin Test introduced in Belgium

The Hartziekenhuis Hospital in Belgium introduced the BÜHLMANN Calprotectin Assay for testing of faecal samples of IBD patients. A thorough evaluation pro  more

Distribution of BioPorto’s NGAL ELISA

In January 2010 BÜHLMANN starts the distribution of the innovative diagnostic products of BioPorto in Switzerland , Austria and France .  more

Get our RSS - Feed